Horizon Therapeutics Denmark ApS: Financial statements 2024
CVR: 43478060
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Horizon Therapeutics Denmark ApS (CVR 43478060) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 500. Equity in the 2024 report amounted to DKK 40,947. The solvency ratio was 89.1%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 500
- Equity
- DKK 40,947
- Total Assets
- DKK 45,947
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Horizon Therapeutics Denmark ApS has published its interim report for the period August 25, 2022 to December 31, 2023.
About Horizon Therapeutics Denmark ApS
Horizon Therapeutics Denmark ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company has been dissolved on 2 September 2025. The company was registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 500. Equity in the 2024 report amounted to DKK 40,947.
